These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19034279)

  • 1. Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment.
    Slade MJ; Payne R; Riethdorf S; Ward B; Zaidi SA; Stebbing J; Palmieri C; Sinnett HD; Kulinskaya E; Pitfield T; McCormack RT; Pantel K; Coombes RC
    Br J Cancer; 2009 Jan; 100(1):160-6. PubMed ID: 19034279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.
    Daskalaki A; Agelaki S; Perraki M; Apostolaki S; Xenidis N; Stathopoulos E; Kontopodis E; Hatzidaki D; Mavroudis D; Georgoulias V
    Br J Cancer; 2009 Aug; 101(4):589-97. PubMed ID: 19623181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.
    Fehm T; Hoffmann O; Aktas B; Becker S; Solomayer EF; Wallwiener D; Kimmig R; Kasimir-Bauer S
    Breast Cancer Res; 2009; 11(4):R59. PubMed ID: 19664291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients.
    Molloy TJ; Bosma AJ; Baumbusch LO; Synnestvedt M; Borgen E; Russnes HG; Schlichting E; van't Veer LJ; Naume B
    Breast Cancer Res; 2011 Jun; 13(3):R61. PubMed ID: 21672237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
    Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
    Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients.
    Hartkopf AD; Wallwiener M; Hahn M; Fehm TN; Brucker SY; Taran FA
    Cancer Res Treat; 2016 Jan; 48(1):115-24. PubMed ID: 25687853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
    Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
    Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
    Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
    BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous detection of circulating and disseminated tumor cells in primary breast cancer patients following neoadjuvant chemotherapy.
    Walter VP; Taran FA; Wallwiener M; Hahn M; Brucker SY; Hartkopf AD
    Arch Gynecol Obstet; 2018 Mar; 297(3):785-790. PubMed ID: 29380106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.
    Falck AK; Bendahl PO; Ingvar C; Isola J; Jönsson PE; Lindblom P; Lövgren K; Rennstam K; Fernö M; Rydén L
    BMC Cancer; 2012 Sep; 12():403. PubMed ID: 22963449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
    Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
    Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of circulating or disseminated tumor cells with the Oncotype DX Recurrence Score.
    Singh P; Tevis SE; Hall CS; Meas S; Hwang RF; Lucci A
    Breast Cancer Res Treat; 2020 Dec; 184(3):683-687. PubMed ID: 32888140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
    Mathiesen RR; Borgen E; Renolen A; Løkkevik E; Nesland JM; Anker G; Ostenstad B; Lundgren S; Risberg T; Mjaaland I; Kvalheim G; Lønning PE; Naume B
    Breast Cancer Res; 2012 Aug; 14(4):R117. PubMed ID: 22889108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer.
    Magbanua MJM; Yau C; Wolf DM; Lee JS; Chattopadhyay A; Scott JH; Bowlby-Yoder E; Hwang ES; Alvarado M; Ewing CA; Delson AL; Van't Veer LJ; Esserman L; Park JW
    Clin Cancer Res; 2019 Sep; 25(17):5388-5397. PubMed ID: 31142502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
    Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
    BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for the presence of tumor cells in bone marrow and peripheral blood in breast cancer patients.
    Cabinakova M; Mikulova V; Malickova K; Vrana D; Pavlista D; Petruzelka L; Zima T; Tesarova P
    Neoplasma; 2015; 62(2):259-68. PubMed ID: 25591591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells.
    Schmitt M; Foekens JA
    Breast Cancer Res; 2009; 11(5):109. PubMed ID: 19833005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy.
    Payne RE; Hava NL; Page K; Blighe K; Ward B; Slade M; Brown J; Guttery DS; Zaidi SA; Stebbing J; Jacob J; Yagüe E; Shaw JA; Coombes RC
    Br J Cancer; 2012 Jan; 106(2):375-82. PubMed ID: 22166803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and Predictive Value of Circulating and Disseminated Tumor Cells in Breast Cancer: A National Cancer Database (NCDB) Analysis.
    Bilani N; Elson L; Liang H; Elimimian EB; Arteta-Bulos R; Nahleh Z
    Technol Cancer Res Treat; 2020; 19():1533033820980107. PubMed ID: 33287661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.